glp-1 kidney outcomes news Renal of SGLT2 inhibitors and GLP1 agonists in clinical practice GLP-1 and the kidney: from

Rybelsus Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist medication that contains semaglutide, the same active ingredient as Ozempic

doi: 10.1016/j.tem.2019.05.008 190 KieczykowskaMKocotJPadziorMMusikI

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver

Table 3 shows positive results on the biological properties of Se-enriched plants and some food ingredients (microalgae, probiotics bacteria and milk casein) in the in vivo animal models compared with Se-enriched yeast, an alternative source of SeMet (around 60-84%) with a lower toxic effect (87, 88)

References / Links Beverley Greenwood-Van Meerveld, Ph.D